Affymax
From Verify.Wiki
Affymax, Inc. is a biopharmaceutical company previously committed to developing novel drugs to improve the treatment of serious and often life-threatening conditions. Our vision was to become a leader in the nephrology and specialty care space by delivering innovative therapeutic offerings to patients and healthcare providers before a nationwide voluntary recall of OMONTYS® (peginesatide) Injection in February 2013. In March 2013 Affymax commenced a review of strategic alternatives.
 | |
| | |
| Type | Public / Private |
Contents
History
Controversies
Top 5 Recent Tweets
| Date | Author | Comment |
|---|---|---|
| March 15, 2023 | DavidCranmerUn1 | Alex Zaffaroni in 1993, and was eventually based in Santa Clara, California, United States. It began as a unit in A… https://t.co/G3ardX0AbL |
| March 15, 2023 | DavidCranmerUn1 | model in rabbits using retro-viral transduction techniques. Dr. Daniel St. Louis is currently SVP and GM of Expre… https://t.co/Cs8Bs70MkL |
Top 5 Recent News Headlines
Top 5 Lifetime Tweets
Top 5 Lifetime News Headlines
Verification history
1,372 days ago- View all verifications
